We provide you with 20 years of free, institutional-grade data for CBAY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CBAY. Explore the full financial landscape of CBAY stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-02-28 | 1042074 | CBAY | 10-K | Url |
| 2023-11-07 | 1042074 | CBAY | 10-Q | Url |
| 2023-08-10 | 1042074 | CBAY | 10-Q | Url |
| 2023-05-15 | 1042074 | CBAY | 10-Q | Url |
| 2023-03-23 | 1042074 | CBAY | 10-K | Url |
| 2022-11-14 | 1042074 | CBAY | 10-Q | Url |
| 2022-08-11 | 1042074 | CBAY | 10-Q | Url |
| 2022-05-12 | 1042074 | CBAY | 10-Q | Url |
| 2022-03-17 | 1042074 | CBAY | 10-K | Url |
| 2021-11-10 | 1042074 | CBAY | 10-Q | Url |
| 2021-08-12 | 1042074 | CBAY | 10-Q | Url |
| 2021-05-13 | 1042074 | CBAY | 10-Q | Url |
| 2021-03-25 | 1042074 | CBAY | 10-K | Url |
| 2020-11-05 | 1042074 | CBAY | 10-Q | Url |
| 2020-08-10 | 1042074 | CBAY | 10-Q | Url |
| 2020-05-11 | 1042074 | CBAY | 10-Q | Url |
| 2020-03-16 | 1042074 | CBAY | 10-K | Url |
| 2019-11-05 | 1042074 | CBAY | 10-Q | Url |
| 2019-08-07 | 1042074 | CBAY | 10-Q | Url |
| 2019-05-08 | 1042074 | CBAY | 10-Q | Url |
| 2019-02-28 | 1042074 | CBAY | 10-K | Url |
| 2018-11-06 | 1042074 | CBAY | 10-Q | Url |
| 2018-08-09 | 1042074 | CBAY | 10-Q | Url |
| 2018-05-08 | 1042074 | CBAY | 10-Q | Url |
| 2018-03-15 | 1042074 | CBAY | 10-K | Url |
| 2017-11-08 | 1042074 | CBAY | 10-Q | Url |
| 2017-08-10 | 1042074 | CBAY | 10-Q | Url |
| 2017-05-11 | 1042074 | CBAY | 10-Q | Url |
| 2017-03-23 | 1042074 | CBAY | 10-K | Url |
| 2016-11-09 | 1042074 | CBAY | 10-Q | Url |
| 2016-08-09 | 1042074 | CBAY | 10-Q | Url |
| 2016-05-11 | 1042074 | CBAY | 10-Q | Url |
| 2016-03-29 | 1042074 | CBAY | 10-K | Url |
| 2015-11-12 | 1042074 | CBAY | 10-Q | Url |
| 2015-08-11 | 1042074 | CBAY | 10-Q | Url |
| 2015-05-11 | 1042074 | CBAY | 10-Q | Url |
| 2015-03-23 | 1042074 | CBAY | 10-K | Url |
| 2014-11-14 | 1042074 | CBAY | 10-Q | Url |
| 2014-08-14 | 1042074 | CBAY | 10-Q | Url |
| 2014-05-15 | 1042074 | CBAY | 10-Q | Url |
| 2014-04-08 | 1042074 | CBAY | S-1 | Url |
| 2014-03-31 | 1042074 | CBAY | 10-K | Url |
| 2013-11-29 | 1042074 | CBAY | S-1 | Url |
| 2013-11-25 | 1042074 | CBAY | 10-Q | Url |
CymaBay Therapeutics, Inc(NASDAQ:CBAY) 
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has com...
Website: http://www.cymabay.com
Founded: 1988
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CBAY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.